Gabriel Lenz: Adjuvant Anti-Inflammatory Therapy in Postoperative Colorectal Cancer
Gabriel Lenz, Internal Medicine Resident, PGY-1 at AdventHealth Central Florida, shared a post on X about a paper he co-authored with colleagues published in Clinical Colorectal Cancer:
“Another article published in a high-impact journal. The article is in press and already available to read.”
Tiago Biachi de Castria, Medical Oncologist, Associate Member at Moffitt Cancer Center and Associate Professor at the University of South Florida, shared this post, adding:
“Proud mentor time: Important data, it confirms that aspirin/NSAID play an important role in adjuvant setting for CRC, and it raises discussion about sequencing stage III colorectal cancer.
Great job guys!”
Title: Adjuvant Anti-Inflammatory Therapy in Postoperative Colorectal Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Authors: Gabriel Lenz, Rafael Alvim Pereira, Gabriel Valagni, Tiago Biachi de Castria
You can read the Full Article on Clinical Colorectal Cancer.
More posts featuring Tiago Biachi de Castria.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023